SCHEMBL5542809

SCHEMBL5542809

CCOC(=O)N1CCN(c2ccc(O)cc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 1.00
GAA P10253 4/20 1.00
LMNA P02545 3/20 1.00
KDM4E B2RXH2 1/20 1.00
ALDH1A1 P00352 7/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
HTT P42858 2/20 0.65
MAPK1 P28482 1/20 0.65
HPGD P15428 1/20 0.57
TSHR P16473 1/20 0.57
CASP1 P29466 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
TDP1 Q9NUW8 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
ABL1 P00519 1/20 0.53
POLB P06746 1/20 0.53
RIN1 Q13671 1/20 0.53
ME2 P23368 2/20 0.52
ME1 P48163 2/20 0.52
ME3 Q16798 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5536209 0.89 MAPT (0.81) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL15127501 0.89 MAPT (0.79) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL5542804 0.87 MAPT (0.77) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL5539971 0.87 MAPT (0.76) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL11889801 0.86 MAPT (0.74) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL2581059 0.86 MAPT (0.75) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL5541814 0.86 MAPT (0.74) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL27610366 0.85 MAPT (0.74) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL5274074 0.85 MAPT (0.74) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL5535580 0.84 MAPT (0.72) MAPTGAALMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117756751-A Preparation method of 4- (4-hydroxyphenyl) -1-piperazine carboxylic acid ethyl ester 宿迁晨阳医药科技有限公司 2024-03-26 CN claimed
CN-101665490-B Method for preparing ketoconazole derivatives EAST ASIA PHARMACEUTICAL CHEMICAL CO LTD 2012-01-04 CN claimed
CN-101665490-A Method for preparing ketoconazole derivatives EAST ASIA PHARMACEUTICAL CHEMI 2010-03-10 CN claimed
CN-117756751-B Preparation method of 4- (4-hydroxyphenyl) -1-piperazine carboxylic acid ethyl ester 宿迁晨阳医药科技有限公司 2025-07-15 CN disclosed
CN-117756751-B Preparation method of 4- (4-hydroxyphenyl) -1-piperazine carboxylic acid ethyl ester 宿迁晨阳医药科技有限公司 2025-07-15 CN disclosed
CN-117756751-A Preparation method of 4- (4-hydroxyphenyl) -1-piperazine carboxylic acid ethyl ester 宿迁晨阳医药科技有限公司 2024-03-26 CN disclosed
CN-117756751-A Preparation method of 4- (4-hydroxyphenyl) -1-piperazine carboxylic acid ethyl ester 宿迁晨阳医药科技有限公司 2024-03-26 CN disclosed
CN-117756751-A Preparation method of 4- (4-hydroxyphenyl) -1-piperazine carboxylic acid ethyl ester 宿迁晨阳医药科技有限公司 2024-03-26 CN disclosed
CN-102532162-B 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMA CO LTD 2015-05-27 CN disclosed
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
CN-101665490-A Method for preparing ketoconazole derivatives EAST ASIA PHARMACEUTICAL CHEMI 2010-03-10 CN disclosed
CN-101665490-A Method for preparing ketoconazole derivatives EAST ASIA PHARMACEUTICAL CHEMI 2010-03-10 CN disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 US disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed
US-4358449-A 1-(1,3-Dioxolan-2-ylmethyl)-1H-1,2,4-triazoles and compositions JANSSEN PHARMACEUTICA, N.V. (BE) 1982-11-09 US disclosed
US-4335125-A FUNGICIDES, BACTERICIDES JANSSEN PHARMACEUTICA, N.V. (BE) 1982-06-15 US disclosed
US-4223036-A FUNGICIDES, BACTERICIDES JANSSEN PHARMACEUTICA N.V. (BE) 1980-09-16 US disclosed
US-4144346-A FUNGICIDES, BACTERICIDES JANSSEN PHARMACEUTICA N.V. (BE) 1979-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 MAPT 4117/4885GAA 4165/4885LMNA 4152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.